Transcripts

Agios Pharmaceuticals (AGIO) earnings call transcripts

Every Agios Pharmaceuticals, Inc. earnings call Gloomberb has transcribed, with a summary, the guidance given, and what analysts pressed on.

Open AGIO in Gloomberb →
  • Q2 2026 earnings call

    Management framed the quarter as disciplined launch execution, with thalassemia broadening beyond early adopters and sickle-cell preparation becoming the next catalyst. $5 million of U.S.

    Jul 30, 2026Confident0.82